PubMed Lincoff AM, Brown-Frandsen K, Colhoun HM, et al
Auch hierfr gilt: Es handelt sich um eine nicht zugelassene Forschungssubstanz ohne belastbare Humanevidenz
The GLP-1 receptor agonist semaglutide better known by its brand names Ozempic and Wegovy has transformed diabetes and obesity management in recent years
PMID: 39498283
As someone who attends many events, parties, and appointments (rough life, I know), it was refreshing to get to get a first look at a brand as the founder wanted me to see it
Additionally, if gastrointestinal side effects persist beyond the first 8-12 weeks of treatment or worsen over time rather than improving, discuss this with your provider, as it may indicate the need for alternative treatment approaches